Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Fertilo In Vitro Research Study and Trial

NCT: NCT06858111 · RECRUITING

NCT IDNCT06858111
StatusRECRUITING
Start Date2025-04-17
Completion2028-01
SponsorGameto, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to evaluate the safety and efficacy of using Fertilo for In vitro maturation (IVM) in participants 18-35 years of age. The main question it aims to answer is whether the use of Fertilo is superior to using Medicult IVM for In vitro maturation. Researchers will compare the number of ongoing pregnancies at 12 weeks gestation for participants in each arm. * Arm 1 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Fertilo for 30 hours. * Arm 2 participants will have all cumulus oocyte complexes (COCs), or eggs surrounded by helper cells, cultured in Medicult IVM for 30 hours.

Frequently Asked Questions

What is Fertilo In Vitro Research Study and Trial?

Fertilo In Vitro Research Study and Trial is a clinical trial registered under NCT06858111. Current status: RECRUITING.

What is the status of NCT06858111?

The current status of NCT06858111 (Fertilo In Vitro Research Study and Trial) is: RECRUITING.

When did Fertilo In Vitro Research Study and Trial start?

Fertilo In Vitro Research Study and Trial started on 2025-04-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.